Doctor Sithenkosi Mlala obtained his MSc in Chemistry (2016) and PhD in Chemistry (2020) from the University of Fort Hare (UFH), Alice, South Africa. He is now an n-GAP lecturer and natural products researcher in the Department of Chemistry at UFH. His work has produced five publications presented at local and international conferences. He has focused on pentacyclic triterpenoids, essential oils, Nuclear Magnetic Resonance (NMR), Fourier Transform Infra-Red (FTIR), Mass Spectrometry (MS), Gas Chromatography–Mass Spectrometry (GC/MS), and testing the bioactivity of drugs. He is a member of the South African Chemical Institute (SACI). His paper in Molecules is currently the second most cited in April 2024. He is an emerging scientist with skills for extracting triterpenoids from different parts of
medicinal plants, isolating and purifying the compounds through column chromatography and thin-layer chromatography, and using the mentioned spectroscopic techniques, except for GC/MS, to identify the components. The activities of the drugs and oils were evaluated against human life-threatening diseases, such as several cancers, oxidants, bacteria, viruses, inflammation, fungi, hypertension, Alzheimer's disease, diabetes, and MTB. The oils were tested for perfumery and medicinal efficacy. He is currently working on drug development and semi-synthesis of heterocyclics to improve solubility in H2O, bioavailability, and targeting scope, with fewer or no side effects.
Doctor Sithenkosi Mlala obtained his MSc in Chemistry (2016) and PhD in Chemistry (2020) from the University of Fort Hare (UFH), Alice, South Africa. He is now an n-GAP lecturer and natural products researcher in the Department of Chemistry at UFH. His work has produced five publications presented at local and international conferences. He has focused on pentacyclic triterpenoids, essential oils, Nuclear Magnetic Resonance (NMR), Fourier Transform Infra-Red (FTIR), Mass Spectrometry (MS), Gas Chromatography–Mass Spectrometry (GC/MS), and testing the bioactivity of drugs. He is a member of the South African Chemical Institute (SACI). His paper in Molecules is currently the second most cited in April 2024. He is an emerging scientist with skills for extracting triterpenoids from different parts of
medicinal plants, isolating and purifying the compounds through column chromatography and thin-layer chromatography, and using the mentioned spectroscopic techniques, except for GC/MS, to identify the components. The activities of the drugs and oils were evaluated against human life-threatening diseases, such as several cancers, oxidants, bacteria, viruses, inflammation, fungi, hypertension, Alzheimer's disease, diabetes, and MTB. The oils were tested for perfumery and medicinal efficacy. He is currently working on drug development and semi-synthesis of heterocyclics to improve solubility in H2O, bioavailability, and targeting scope, with fewer or no side effects.